Optimapharm d.o.o. is a leading, mid-sized, full-service European Contract Research Organization (CRO) that has been providing tailored clinical trial solutions since 2006. Headquartered in Zagreb, Croatia, Optimapharm offers comprehensive services for Phase I-IV clinical trials, medical device studies, and Real World Evidence (RWE) projects across a wide range of therapeutic areas. With a strong operational presence throughout Europe and extending to the USA, they partner with pharmaceutical, biotechnology, and medical device companies to navigate complex regulatory landscapes and efficiently manage clinical research from concept to completion. Optimapharm is committed to delivering high-quality data, adhering to ethical standards, and accelerating the development of new medical treatments.
The Zagreb headquarters serves as the central command for Optimapharm's global operations, strategic decision-making, business development, financial management, and administrative oversight for its extensive network of clinical research activities.
The headquarters is situated in a modern office building, equipped with facilities to support its international team and complex project management requirements. It's designed to foster collaboration and efficiency.
Optimapharm cultivates a professional, dynamic, and scientifically-driven work culture. There's a strong emphasis on teamwork, quality, continuous learning, and client-centric service delivery. Employees are encouraged to be proactive and contribute to the company's mission of advancing healthcare.
The Zagreb headquarters is strategically positioned to manage operations across Central, Eastern, and Western Europe. Its location in Croatia offers access to a skilled workforce and a favorable environment for managing multinational clinical trials. It represents the core of Optimapharm's growth and European expertise.
Optimapharm d.o.o. has a significant global presence, primarily focused on Europe where it operates in over 25 countries, including Western, Central, and Eastern Europe. Its reach also extends to the United States. Globally, Optimapharm supports a full spectrum of clinical research functions: comprehensive clinical trial management (Phase I-IV), regulatory affairs and submissions, medical writing, pharmacovigilance, data management, biostatistics, site selection and management, patient recruitment, and quality assurance. This expansive network allows Optimapharm to conduct complex, multinational clinical trials for pharmaceutical, biotechnology, and medical device companies worldwide.
Ulica Frana Folnegovića 1c/II
Zagreb
Grad Zagreb
Croatia
Address: Optimapharm GmbH, Fraunhoferstr. 9a, 82152 Planegg, Germany
To provide localized expertise and robust support for clinical research activities in Germany, leveraging the country's advanced medical infrastructure and large patient pool. Ensures compliance with German and EU regulations.
Address: Optimapharm Ltd., Office 7, 35-37 Ludgate Hill, London, EC4M 7JN, UK
To maintain a strong presence in the important UK market, navigating its specific regulatory environment post-Brexit and supporting clinical trials for both local and international sponsors.
Address: Optimapharm Inc. (formerly SSS International Clinical Research), 451 Hungerford Dr Ste 220, Rockville, MD 20850, USA
To provide comprehensive clinical research solutions for clients targeting the U.S. market, manage U.S.-based trials, and facilitate global studies that include North American sites. Crucial for engagement with the FDA and U.S. biotech/pharma industry.
Address: Optimapharm Sp. z o.o., ul. Domaniewska 39A, 02-672 Warszawa, Poland
To leverage Poland's capabilities as a significant location for clinical trials in Eastern Europe, known for efficient patient recruitment and experienced investigators, while ensuring adherence to local and EU guidelines.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Optimapharm' leadership includes:
Optimapharm has been backed by several prominent investors over the years, including:
In the last 12 months, Optimapharm d.o.o. announced a key new appointment to its executive team, strengthening its financial leadership. No major executive departures have been publicly announced during this period.
Discover the tools Optimapharm uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Optimapharm d.o.o.'s specific email format is not publicly displayed, a common pattern for professional organizations like Optimapharm is [first].[last]@[companydomain.com]. Variations such as [first_initial][last]@[companydomain.com] might also be in use.
[first].[last]@optimapharm.eu
Format
jane.doe@optimapharm.eu
Example
80%
Success rate
Optimapharm Website / PR Newswire • 2024-04-17
Optimapharm announced the acquisition of anevis solutions GmbH, a German CRO specializing in early phase clinical trials and solutions for medical devices and in-vitro diagnostics. This strategic move enhances Optimapharm's capabilities in early clinical development and expands its footprint in the DACH region....more
Optimapharm Website / Business Wire • 2024-01-16
Optimapharm completed the acquisition of Crown CRO, a CRO with strong presence in Finland, Sweden, Norway, Denmark, Estonia, Latvia, and Lithuania. This acquisition significantly expands Optimapharm’s geographical coverage into the Benelux and Scandinavian regions....more
PR Newswire • 2023-09-06
Optimapharm announced the appointment of Stjepko Čumpek as its new Chief Financial Officer. Mr. Čumpek brings over 20 years of experience in finance and management, aiming to support Optimapharm's strategic growth initiatives....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Optimapharm, are just a search away.